E
E. Blümner
Publications - 3
Citations - 128
E. Blümner is an academic researcher. The author has contributed to research in topics: Bromocriptine & Benserazide. The author has an hindex of 3, co-authored 3 publications receiving 125 citations.
Papers
More filters
Journal ArticleDOI
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.
Horst Przuntek,D. Welzel,M. Gerlach,E. Blümner,W. Danielczyk,H. J. Kaiser,Peter H. Kraus,H. Letzel,P. Riederer,K. Überla +9 more
TL;DR: Partial substitution of levodopa by bromocriptine (>30%) as first-line treatment of Parkinson's disease proves active in the prophylaxis oflevodopa associated motor side effects.
Journal ArticleDOI
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.
Horst Przuntek,D. Welzel,E. Blümner,W. Danielczyk,H. Letzel,H. J. Kaiser,P. H. Kraus,P. Riederer,D. Schwarzmann,H. Wolf,K. Überla +10 more
TL;DR: The results imply that combination therapy with bromocriptine should be preferred over L-Dopa monotherapy from the very beginning.
Journal ArticleDOI
Meta‐analyses on passive smoking and lung cancer effects of study selection and misclassification of exposure
H. Letzel,E. Blümner,K. Überla +2 more
TL;DR: Meta‐analyses of studies on lung cancer and passive smoking both by WALD and the authors have shown greater differences in the pooled relative risk, leading to the conclusion that based on meta‐an analyses with proper correction for misclassification the null hypothesis has to be further accepted.